Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future
/in Dendritic Cells, Gallbladder Cancer, International PublicationsImmunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
/in International Publications, IOZK VeröffentlichungenMtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian CancerCurrent and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial CarcinomaExtracellular vesicles as emerging targets in cancer: Recent development from bench to bedside
/in Exosome, International PublicationsSerum selenium levels predict survival after breast cancer
/in International Publications, MicronutrientsRethinking liquid biopsy: Microfluidic assays for mobile tumor cells in human body fluids
/in Exosome, International PublicationsDendritic cell therapy in melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaDendritic cells based immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications, Pancreatic Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer